- 
	
	A Switch From Intravenous to Oral Chemo?Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients. by Ashley P. Taylor 
- 
	
	Avoiding Unnecessary Lymph Node BiopsyA study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed. by Cheryl Platzman Weinstock 
- 
	
	December 6: The Week in Cancer NewsA study suggests an association between hair dye use and breast cancer, and the U.S. Food and Drug Administration adds a new indication for an immunotherapy-chemotherapy combination. by Kate Yandell 
- 
	
	Encouraging Beneficial Gut MicrobesNutritional epidemiologist Carrie Daniel-MacDougall discusses research suggesting that what patients eat affects their gut microbes—and could influence cancer immunotherapy response. by Anna Azvolinsky 
- 
	
	Cancer Takes an Unequal Toll on EmploymentIn a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment. by Pamela Rafalow Grossman 
- 
	
	Cancer and CreditThe financial burden of a cancer diagnosis can lower a patient's credit score. by Shelly Rosenfeld 
- 
	
	November 22: The Week in Cancer NewsData from Northern Ireland suggest a fifth of cancer diagnoses are made in the emergency department, and a study investigates how the nervous system might be harnessed for cancer treatment. by Bradley Jones 
- 
	
	November 15: The Week in Cancer NewsA study suggests the rate of melanoma diagnoses in adolescents and young adults is falling, and a health care reporter writes about the many difficult decisions she had to make after her cancer diagnosis. by Kate Yandell 
- 
	
	Treating Fear of RecurrenceCognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say. by Jon Kelvey 
- 
	
	November 8: The Week in Cancer NewsSome oncologists do not discuss the costs of genomic testing and resulting treatments with their patients, and preliminary results indicate that a cancer therapy using the CRISPR gene-editing technique is safe. by Kate Yandell 
Cancer Talk
	
	
					
				Treatment Combination Improves Survival in EGFR-positive Lung Cancer
				
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
 
					 
					 
					 
					 
					 
					 
					 
					 
					 
					 
					
 
					 
					